Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Sell
9,716
-3
-0% -$1.07K 0.79% 50
2025
Q4
$3.18M Sell
9,719
-529
-5% -$168K 0.77% 54
2025
Q3
$2.89M Buy
10,248
+107
+1% +$31K 0.69% 61
2025
Q2
$2.83M Buy
10,141
+86
+0.9% +$24.4K 0.76% 59
2025
Q1
$3.13M Buy
10,055
+138
+1% +$40.8K 0.89% 53
2024
Q4
$2.58M Buy
+9,917
New +$2.94M 0.74% 61
2024
Q2
$2.16M Buy
6,907
+687
+11% +$202K 1.06% 44
2024
Q1
$1.77M Buy
6,220
+1,209
+24% +$354K 0.98% 51
2023
Q4
$1.44M Buy
+5,011
New +$1.37M 1.04% 47

Other funds holding AMGN

JPL Wealth Management's AMGN Position: Q1 2026 in Review

JPL Wealth Management reduced its Amgen (AMGN) stake by 0.03% in Q1 2026, selling an estimated $1.07K and leaving 9,716 shares worth $3.42M. The position accounts for 0.79% of the portfolio, ranked #50.

JPL Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • JPL Wealth Management held 9,716 shares of Amgen worth $3.42M as of Q1 2026.
  • JPL Wealth Management sold 3 Amgen shares in Q1 2026, an estimated $1.07K.
  • Amgen made up 0.79% of JPL Wealth Management's portfolio in Q1 2026, its #50 holding.
  • JPL Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.